First Light Asset Management Boosts Twist Bioscience Stake

Investment firm increases position in biotech company by 26.4% in Q3

Mar. 16, 2026 at 10:05am

Got story updates? Submit your updates here. ›

First Light Asset Management LLC increased its stake in Twist Bioscience Corporation (NASDAQ:TWST) by 26.4% in the third quarter, according to a recent SEC filing. The firm now owns 1,194,883 shares of the company's stock, making it Twist Bioscience's 9th largest shareholder and representing 1.98% ownership.

Why it matters

Twist Bioscience is a leading synthetic biology company that specializes in DNA synthesis and gene engineering. The increase in First Light's position suggests the investment firm sees significant growth potential in Twist's business and technology.

The details

According to the filing, First Light Asset Management purchased an additional 249,850 shares of Twist Bioscience during the third quarter, bringing its total position to 1,194,883 shares. This represents 3.2% of First Light's overall portfolio. Other major institutional investors in Twist Bioscience include ARK Investment Management, Artisan Partners, and William Blair Investment Management.

  • First Light Asset Management increased its Twist Bioscience stake in the third quarter of 2026.

The players

First Light Asset Management LLC

An investment management firm that focuses on public equities and owns a 1.98% stake in Twist Bioscience.

Twist Bioscience Corporation

A synthetic biology company that specializes in DNA synthesis and gene engineering.

Got photos? Submit your photos here. ›

The takeaway

The increase in First Light's position in Twist Bioscience suggests the investment firm sees strong growth potential in the biotech company's innovative DNA synthesis platform and gene engineering capabilities.